Literature DB >> 30386

[Absorption, elimination and metabolism of a new neuroleptic agent (FLO 1347) in the rat dog and man (author's transl)].

M Strolin-Benedetti, A Donath, A Frigerio, K T Morgan, C Laville, A Malnoe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 30386

Source DB:  PubMed          Journal:  Ann Pharm Fr        ISSN: 0003-4509


× No keyword cloud information.
  6 in total

1.  Single oral dose pharmacokinetics of tiapride in patients with Huntington's disease.

Authors:  T Norman; E Chiu; R H James; M S Gregory
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Pharmacokinetics of tiapride in patients with tardive dyskinesia and Huntington's disease.

Authors:  R A Roos; E J de Haas; O J Buruma; F A de Wolff
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Absorption, metabolism and excretion of 14C-sultopride in the rat.

Authors:  K Dross; P Sillmann; J Küster
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

Review 4.  Tiapride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in geriatric agitation.

Authors:  J W Steele; D Faulds; E M Sorkin
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

Review 5.  Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome.

Authors:  D H Peters; D Faulds
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

6.  Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride.

Authors:  Stefanie Fekete; K Egberts; T Preissler; C Wewetzer; C Mehler-Wex; M Romanos; M Gerlach
Journal:  Eur J Clin Pharmacol       Date:  2020-09-28       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.